Schedule 13G ownership disclosure

Puma Biotechnology Inc

Common Stock, $0.0001 par value per share · CUSIP: 74587V107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ACORN BIOVENTURES, L.P.

    Shares: 1,654,823.00 · Class: 3.3%

  • ACORN BIOVENTURES 2, L.P.

    Shares: 2,285,229.00 · Class: 4.7%

  • ACORN CAPITAL ADVISORS GP, LLC

    Shares: 1,654,823.00 · Class: 3.3%

  • Anders Hove

    Shares: 3,940,052.00 · Class: 8.0%

  • Acorn Capital Advisors GP 2, LLC

    Shares: 285,229.00 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001636587-25-000007
Form type
SCHEDULE 13G/A
Filer
ACORN BIOVENTURES, L.P.
CIK
CIK 1766853
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub